The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline. - Wikidata - awgldk - TriplyDB

The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline.

The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline.

http://www.wikidata.org/entity/Q30425097

about

Effect of Low-Density Lipoprotein Cholesterol Lowering by Ezetimibe/Simvastatin on Outcome Incidence: Overview, Meta-Analyses, and Meta-Regression Analyses of Randomized Trials Non-invasive vulnerable plaque imaging: how do we know that treatment works?Clinical efficacy and safety of Ezetimibe on major cardiovascular endpoints: systematic review and meta-analysis of randomized controlled trials MRI in Lower Extremity Peripheral Arterial Disease: Recent Advancements.Multimodality imaging of lower extremity peripheral arterial disease: current role and future directions.Usefulness of cardiovascular magnetic resonance imaging of the superficial femoral artery for screening patients with diabetes mellitus for atherosclerosis.LDL lowering in peripheral arterial disease: are there benefits beyond reducing cardiovascular morbidity and mortality?Low-density lipoprotein lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease.The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT)Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010.Ezetimibe-Statin Combination Therapy.Aliskiren effect on plaque progression in established atherosclerosis using high resolution 3D MRI (ALPINE): a double-blind placebo-controlled trial.Therapeutic strategies to deplete macrophages in atherosclerotic plaques.Lipid-lowering therapy in chronic kidney disease: is there a role for ezetimibe?Novel metabolic biomarkers of cardiovascular disease.Carotid atherosclerotic plaque stenosis: the stabilizing role of statins.Dyslipidemia Part 2: Review of Dyslipidemia Treatment in Patients With Noncoronary Vascular Disease.Pathophysiology of peripheral arterial disease in diabetes mellitus.MR imaging-verified plaque delipidation with lipid-lowering therapy important questions remain.Ezetimibe prescriptions in older Canadian adults after an acute myocardial infarction: a population-based cohort study.Recent advances in magnetic resonance imaging for peripheral artery disease.Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis.

P2860

Q26797486-8943C96D-D7B2-4405-A045-C760EC2BAB29 Q27020959-AA2BA3DB-DB2D-4B66-887B-F33125FFBFCC Q28546769-135C3803-6A0B-49FE-8A94-184714967146 Q30414980-E53ED145-89A3-4F20-AEB9-80BF0BED63B3 Q30416517-96A5DC69-4573-4FFE-B5CE-2E5888EAF937 Q30418403-ECF4319E-91CD-4F2C-92BA-FB616FD31D8E Q30422549-E6A5BA3E-5060-4D40-98C3-63A635A2664A Q30430614-99A10CF7-D35D-4ABF-8964-D747E1A53D44 Q30662013-0661768F-4B42-4247-B60B-1C7E57ACFF3D Q34400871-23DAD842-2C51-415A-A2CA-1B32E0E21BD1 Q36076916-1D5ED182-0B18-4707-902F-59676ABE3006 Q36974370-61C36A61-6EB1-4BD6-9D6A-4227B81C978A Q37981725-6318A15D-0DB0-4730-9102-0EF1425BFB00 Q38011919-57A19FDE-CB92-46C6-922D-3DCE2654EB34 Q38245327-82E0EA2C-CECD-45D5-A212-AE2A753BEBCC Q38251322-C696C5AB-69E9-4793-887D-CDA575528E16 Q38777322-CAF6C659-A6EB-4772-8679-32A6A87B95AA Q38936026-CABFF948-617D-4542-A2CA-411A89B81425 Q42578659-B9F1F1B3-C4EB-44B1-8B06-815D48701D78 Q47746024-B743ADC7-7A4A-4CC7-91C6-B27719AAC9E5 Q55257450-A2979251-2C72-464E-8B03-55585F0A0BC2 Q55398460-9D7DB3EA-0AC5-477F-BE68-AEFFCDE854D1

P2860

The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline.

http://www.wikidata.org/entity/Q30425097

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

The effect of ezetimibe on per ...... s upon statin use at baseline.

@ast

The effect of ezetimibe on per ...... s upon statin use at baseline.

@en

type

label

The effect of ezetimibe on per ...... s upon statin use at baseline.

@ast

The effect of ezetimibe on per ...... s upon statin use at baseline.

@en

prefLabel

The effect of ezetimibe on per ...... s upon statin use at baseline.

@ast

The effect of ezetimibe on per ...... s upon statin use at baseline.

@en

P1433

Q30425097-D3CAAB47-4BCA-447B-B564-8D73A78008BC

P1476

Q30425097-5F3EF6E6-957E-4503-96EB-C8DECA4FCC0C

P2093

Q30425097-246368E7-DD85-4AE5-ADC5-869DE2A4F0FF

Q30425097-76DA8F33-3F5B-42FE-8831-CAB4BEB379E7

Q30425097-844B4351-CF44-435F-9EB1-14C005703897

Q30425097-92DDC5BC-B117-4399-AAA3-0C2BE2A146AB

Q30425097-93A314C5-E55A-491A-809A-27BB7C00209C

Q30425097-AC717DC0-9A40-45CF-B6BD-AE2453A8BF9B

Q30425097-C229DD41-A823-4A13-8FB8-51E40D42645C

Q30425097-C31A7F64-4826-4EBC-8189-62908ECB1826

Q30425097-C687A274-22D8-4508-A92C-DAD56000D305

Q30425097-C6F96312-9CED-4257-8A4D-9AF925FCCBC8

P2860

Q30425097-0144A635-F74C-4CBD-920A-575B098005CC

Q30425097-036B0D04-1800-474D-B70B-97B025CC959B

Q30425097-052DC54E-9127-4A7F-91FD-54A45970C581

Q30425097-108325F2-6D85-47A5-9A55-5183B9A87172

Q30425097-17106FB3-99F9-48B4-80FE-3B6D0FD11EDB

Q30425097-23663C1D-D0CF-4817-910A-746F21BFE32C

Q30425097-24D8F220-2D61-457E-AA28-5E93A58FDAB7

Q30425097-2966B645-590B-422E-9610-85244FFFD68E

Q30425097-3CA9E9CC-3F15-4AC3-B42C-13E4F68EAAE9

Q30425097-3ED34C07-3518-4B6C-8DE8-390345381EDE

P304

Q30425097-BBA6C116-CD83-4183-ABCD-BBF0A64E2502

P31

Q30425097-F8F79C4D-365A-46F3-8CFB-73AE88A51B71

P356

Q30425097-A6C92A5F-15C3-4194-AEE4-5ED3AE5B6E66

P433

Q30425097-7F39BCA1-3F48-4F6C-B081-D00B4257CDEE

P478

Q30425097-4A2DFD27-0BFB-4821-BB6A-1AFB2A24A4C5

P50

Q30425097-0DEBD812-D7AF-4B4F-93E6-0DCA2C80BD4C

Q30425097-68DF207D-991E-4741-8CA1-2C8518FADB5E

Q30425097-F1D40D9B-E9F0-4614-B05E-60A791042E4B

P577

Q30425097-B702A242-F4D6-48BB-9365-953A854F428D

P5875

Q30425097-70986744-C060-4058-AB51-080FE0D45E72

P698

Q30425097-9AEBF99B-6E5D-4DB9-AE96-C700CA1F8230

P921

Q30425097-8163CA0E-B5B3-405C-8B5B-2D9799F4AAF6

P932

Q30425097-96F0AACB-153C-425C-AB0C-D6FC16131FBC

P356

J.ATHEROSCLEROSIS.2011.04.005

P1433

Atherosclerosis

P1476

The effect of ezetimibe on per ...... s upon statin use at baseline.

@en

P2093

Amy M West

http://www.w3.org/2001/XMLSchema#string

Craig H Meyer

http://www.w3.org/2001/XMLSchema#string

Gabriel B Winberry

http://www.w3.org/2001/XMLSchema#string

Hongkun Wang

http://www.w3.org/2001/XMLSchema#string

Jennifer R Hunter

http://www.w3.org/2001/XMLSchema#string

John M Christopher

http://www.w3.org/2001/XMLSchema#string

Joseph M DiMaria

http://www.w3.org/2001/XMLSchema#string

Joshua D Chew

http://www.w3.org/2001/XMLSchema#string

Justin D Anderson

http://www.w3.org/2001/XMLSchema#string

Nancy L Harthun

http://www.w3.org/2001/XMLSchema#string

P2860

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Peripheral arterial disease detection, awareness, and treatment in primary care

Simvastatin with or without ezetimibe in familial hypercholesterolemia

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Reproducibility and reliability of atherosclerotic plaque volume measurements in peripheral arterial disease with cardiovascular magnetic resonance.

Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism.

Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial.

Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging.

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial.

P304

156-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ATHEROSCLEROSIS.2011.04.005

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

218

http://www.w3.org/2001/XMLSchema#string

P50

Christopher M Kramer

Frederick H Epstein

Klaus D Hagspiel

P577

2011-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51125243

http://www.w3.org/2001/XMLSchema#string

P698

21570685

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3157540

http://www.w3.org/2001/XMLSchema#string